Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Four-Part Phase-1 Study Investigating the Tolerability, Safety and Pharmacokinetics (PK) of MBS2320 in Healthy Subjects and in Subjects With Rheumatoid Arthritis (RA) Also Treated With Methotrexate

NCT02480946 is registered in ClinicalTrials.gov with Modern Biosciences Ltd as lead sponsor.

NCT NCT02480946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02480946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Four-Part Phase-1 Study Investigating the Tolerability, Safety and Pharmacokinetics (PK) of MBS2320 in Healthy Subjects and in Subjects With Rheumatoid Arthritis (RA) Also Treated With Methotrexate
Lead sponsor
Modern Biosciences Ltd
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2015
Completion date
March 31, 2017
Enrollment
105 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid